Therapeutic Area: Metabolic Endocrine
Medroxyprogesterone Acetate
Long acting reversible contraceptive. Contraceptive, adjuvant therapy of endometrial, renal and breast carcinoma.
Composition:
Medroxyprogesterone Acetate 150 mg/ml
Presentation:
1 vial
Route of administration:
Injectable suspension.
Posology:
At the physician’s discretion.
Division:
Ethic | With medical prescription.
Important:
Product imported and distributed by Vincenti International RIF J-501195749.